Search Results
Educational Sessions: "Genomic and transcriptomic landscape of TNBC"
Educational Sessions: "Optimizing the management of early stage TNBC"
New study identifies promising drug combinations for triple negative breast cancer treatment
Triple negative breast cancer
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
BRCA1/2 gene test | Risk of hereditary breast and ovarian cancer | MedGenome
TNBC- Dr Sudha Sinha, Clinical Director Oncology, Care Hospital, Hyderabad
